LGC Diagnostics & Genomics - Lucigen Reagent Components

LGC Clinical Diagnostics & Genomics

At LGC Diagnostics & Genomics, we drive scientific progress by making our trusted life science solutions both simpler and more innovative.

Partnering with our customers to provide a portfolio of cutting-edge life science tools that diagnose, treat and feed our growing population, delivering on our core mission of Science for a Safer World.

Lucigen Reagent Components

Antibodies, Antigens and Virus‑Like Particles (VLPs)

Lucigen designs and produces advanced biological reagents that support demanding IVD and pharmaceutical applications.

• First‑to‑market virus‑like particle technologies supporting diagnostic and pharmaceutical partners.
• Expertise in highly complex recombinant protein design and production.

Enzymes

Lucigen enzyme solutions are developed to meet performance, consistency and scale requirements across research and commercial workflows.

• Flexible manufacturing from small‑scale pilots to large‑scale production.
• Custom enzyme development and formulation tailored to customer workflows.
• ISO 13485 compliant manufacturing supporting regulated environments.

Competent Cells

Competent cell solutions designed to support molecular biology, MDx and pharmaceutical applications.

• Custom cell line development to meet specific performance requirements.
• Application‑specific quality control aligned to MDx and pharmaceutical standards.

Biological Materials and Disease State Materials (DSM)

A comprehensive portfolio of biological materials designed to support assay development, validation and quality control.

• Advanced processing options including defibrination, diafiltration, delipidization and charcoal stripping.
• Treatment options including BPL and UV to support specific safety and performance requirements.
• Broad sourcing capabilities providing a wide range of disease‑state reactivity profiles.